Innate Pharma

Innate Pharma S.A.
Stock Exchange Other OTC
EPS
$0.04
Market Cap
$421.93 M
Shares Outstanding
57.46 M
Public Float
-
Innate Pharma S.A.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
57.46 M
Public Float
-
Innate Pharma S.A.
Stock Exchange Euronext Paris
EPS
EUR0.05
Market Cap
EUR373.91 M
Shares Outstanding
64.04 M
Public Float
43.05 M

Profile

Address
117, Avenue de Luminy
Marseille Provence-Alpes-Cote-dAzur 13009
France
Employees -
Website http://www.innate-pharma.com/en
Updated 07/08/2019
Innate Pharma SA is a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. Its products include immunotherapy drugs and monoclonal antibodies. The Immunotherapy drugs are designated for cancer and inflammatory diseases.

Financials

View All

Hervé Brailly
Chairman-Supervisory Board & Head-Human Resources
Gilles Brisson
Member-Supervisory Board